ProShare Advisors’s Kezar Life Sciences KZR Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-1,282
| Closed | -$11.6K | – | 1928 |
|
2024
Q1 | $11.6K | Buy |
1,282
+101
| +9% | +$911 | ﹤0.01% | 1993 |
|
2023
Q4 | $11.2K | Sell |
1,181
-221
| -16% | -$2.09K | ﹤0.01% | 1941 |
|
2023
Q3 | $16.7K | Buy |
1,402
+5
| +0.4% | +$60 | ﹤0.01% | 1795 |
|
2023
Q2 | $34.2K | Buy |
1,397
+303
| +28% | +$7.42K | ﹤0.01% | 1806 |
|
2023
Q1 | $34.2K | Sell |
1,094
-149
| -12% | -$4.66K | ﹤0.01% | 1706 |
|
2022
Q4 | $87.5K | Buy |
1,243
+88
| +8% | +$6.19K | ﹤0.01% | 1673 |
|
2022
Q3 | $100K | Buy |
+1,155
| New | +$100K | ﹤0.01% | 1559 |
|
2022
Q2 | – | Sell |
-1,219
| Closed | -$204K | – | 1970 |
|
2022
Q1 | $204K | Sell |
1,219
-237
| -16% | -$39.7K | ﹤0.01% | 1874 |
|
2021
Q4 | $243K | Sell |
1,456
-12
| -0.8% | -$2K | ﹤0.01% | 1909 |
|
2021
Q3 | $127K | Sell |
1,468
-284
| -16% | -$24.6K | ﹤0.01% | 1875 |
|
2021
Q2 | $95K | Buy |
1,752
+275
| +19% | +$14.9K | ﹤0.01% | 2298 |
|
2021
Q1 | $88K | Buy |
1,477
+69
| +5% | +$4.11K | ﹤0.01% | 2180 |
|
2020
Q4 | $73K | Buy |
+1,408
| New | +$73K | ﹤0.01% | 2019 |
|